Stig Linder
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways
- Cell death mechanisms and regulation
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
Papers in
-
- Ubiquitin and proteasome pathways 42
- Cell death mechanisms and regulation 21
- RNA Interference and Gene Delivery 10
- Histone Deacetylase Inhibitors Research 9
- Oncology 46
- Cancer-related Molecular Pathways 18
- Co-authors
- Maria C. Shoshan (32 shared papers)Pádraig D’Arcy (42 shared papers)Maria Hägg Olofsson (24 shared papers)Aleksandra Mandic (6 shared papers)Xiaonan Zhang (19 shared papers)Johan Hansson (7 shared papers)Rolf Larsson (21 shared papers)Mårten Fryknäs (21 shared papers)
- Journals
- International Journal of Cancer (8 papers)PLoS ONE (5 papers)Experimental Cell Research (5 papers)International Journal of Molecular Sciences (4 papers)Genes Chromosomes and Cancer (3 papers)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Stig Linder
150 papers receiving 7.1k citations
Peers
Comparison fields: 5 of 132
- Oncology 1.7k
- Molecular Biology 4.5k
- Cancer Research 888
- Cell Biology 954
- Epidemiology 871
Countries citing papers authored by Stig Linder
This map shows the geographic impact of Stig Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stig Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stig Linder more than expected).
Fields of papers citing papers by Stig Linder
This network shows the impact of papers produced by Stig Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stig Linder. The network helps show where Stig Linder may publish in the future.
Co-authors
The 25 scholars most cited alongside Stig Linder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 414 | |
| 2 | 2003 | 401 | |
| 3 | 2013 | 267 | |
| 4 | 2014 | 258 | |
| 5 | 2004 | 231 | |
| 6 | 2002 | 206 | |
| 7 | 2014 | 198 | |
| 8 | 2004 | 188 | |
| 9 | 2006 | 188 | |
| 10 | 2018 | 170 | |
| 11 | 2012 | 145 | |
| 12 | 2019 | 136 | |
| 13 | 2016 | 135 | |
| 14 | 2007 | 120 | |
| 15 | 2015 | 119 | |
| 16 | 2003 | 108 | |
| 17 | 2004 | 107 | |
| 18 | 2002 | 107 | |
| 19 | 2020 | 102 | |
| 20 | 2012 | 100 |
About Stig Linder
Stig Linder is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Epidemiology, having authored 152 papers that have together received 7.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (42 papers), Cell death mechanisms and regulation (21 papers), Cancer-related Molecular Pathways (18 papers), Cancer, Hypoxia, and Metabolism (16 papers), Endoplasmic Reticulum Stress and Disease (12 papers), RNA Interference and Gene Delivery (10 papers), Autophagy in Disease and Therapy (9 papers) and Histone Deacetylase Inhibitors Research (9 papers). The work is most often cited by research in Oncology (1.7k citations), Molecular Biology (4.5k citations), Cancer Research (888 citations), Cell Biology (954 citations) and Epidemiology (871 citations). Stig Linder has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Maria C. Shoshan, Pádraig D’Arcy, Maria Hägg Olofsson, Aleksandra Mandic, Xiaonan Zhang, Johan Hansson, Rolf Larsson, Mårten Fryknäs, Aleksandra Mandic Havelka and Takayuki Ueno. Their work appears in journals such as International Journal of Cancer, PLoS ONE, Experimental Cell Research, International Journal of Molecular Sciences and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.